| GC38129-5mg |
|
1699720-89-2 |
|
0 |
C20H25N3O3 |
|
|
|
| GC38129-1mg |
|
1699720-89-2 |
|
0 |
C20H25N3O3 |
|
|
|
| GC38128-10mg |
|
— |
c(phg-isoD-G-R-(NMe)k) TFA
|
0 |
C29H42F3N9O9 |
|
|
|
| GC38128-5mg |
|
— |
c(phg-isoD-G-R-(NMe)k) TFA
|
0 |
C29H42F3N9O9 |
|
|
|
| GC38128-1mg |
|
— |
c(phg-isoD-G-R-(NMe)k) TFA
|
0 |
C29H42F3N9O9 |
|
|
|
| GC38127-10mg |
|
2307461-45-4 |
FAK ligand-Linker Conjugate 1
|
0 |
C25H28F3N5O6S |
|
|
|
| GC38127-5mg |
|
2307461-45-4 |
FAK ligand-Linker Conjugate 1
|
0 |
C25H28F3N5O6S |
|
|
|
| GC38127-1mg |
|
2307461-45-4 |
FAK ligand-Linker Conjugate 1
|
0 |
C25H28F3N5O6S |
|
|
|
| GC38126-5mg |
|
100665-44-9 |
Deacetyl Ganoderic Acid F
|
0 |
C30H40O8 |
|
|
|
| GC38126-1mg |
|
100665-44-9 |
Deacetyl Ganoderic Acid F
|
0 |
C30H40O8 |
|
|
|
| GC38125-100mg |
|
122520-79-0 |
|
0 |
C10H7NO4 |
|
|
|
| GC38125-50mg |
|
122520-79-0 |
|
0 |
C10H7NO4 |
|
|
|
| GC38125-25mg |
|
122520-79-0 |
|
0 |
C10H7NO4 |
|
|
|
| GC38125-10mg |
|
122520-79-0 |
|
0 |
C10H7NO4 |
|
|
|
| GC38125-5mg |
|
122520-79-0 |
|
0 |
C10H7NO4 |
|
|
|
| GC38125-2mg |
|
122520-79-0 |
|
0 |
C10H7NO4 |
|
|
|
| GC38125-10mM (in 1mL DMSO) |
|
122520-79-0 |
|
0 |
C10H7NO4 |
|
|
|
| GC38124-100mg |
|
2149584-03-0 |
|
0 |
C37H40N4O5 |
|
|
|
| GC38123-100mg |
|
1260092-50-9 |
Mal-amido-PEG1-C2-NHS ester
|
0 |
C16H19N3O8 |
|
|
|
| GC38122-500mg |
|
253863-34-2 |
Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP
|
0 |
C40H46N6O12 |
|
|
|
